Results 371 to 380 of about 1,468,461 (396)
Some of the next articles are maybe not open access.

Immunotherapy with bispecific antibodies.

Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie, 1995
With rare exceptions, monoclonal antibodies as therapeutic agents for cancer, have had limited anti-tumor effects. Attempts to improve the cytotoxicity of antibodies by using them as guiding agents for immune effector cells, have been developed. Numerous in vitro studies have shown that T lymphocytes can be targeted towards any target cell by using ...
openaire   +2 more sources

mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants

Nature, 2021
Jianliang Xu   +2 more
exaly  

BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection

Nature, 2022
Yunlong Cao, Fanchong Jian, Shuo Du
exaly  

The renaissance of chemically generated bispecific antibodies

Nature Reviews Chemistry, 2021
Peter A. Szijj, V. Chudasama
semanticscholar   +1 more source

Bispecific antibodies: a mechanistic review of the pipeline

Nature reviews. Drug discovery, 2019
A. Labrijn   +3 more
semanticscholar   +1 more source

Human neutralizing antibodies elicited by SARS-CoV-2 infection

Nature, 2020
Jinfang Yu, Jincun Zhao, Jiwan Ge
exaly  

Immunotherapy of cancer in 2012

Ca-A Cancer Journal for Clinicians, 2012
Lisa H Butterfield, Ahmad A Tarhini
exaly  

Bispecific Monoclonal Antibodies [PDF]

open access: possibleClinical Lymphoma Myeloma and Leukemia, 2015
openaire   +1 more source

Application of Nanotechnology in Cancer Therapy and Imaging

Ca-A Cancer Journal for Clinicians, 2008
Dong M Shin
exaly  

Home - About - Disclaimer - Privacy